The increased expression of LAMP3 in the CD4+ T cells from the SLE patients and immunised ND may affect the TCR-antigen interaction by altering the surface expression of TCR and co-stimulatory molecules, such as CD28 and ICOS. Here, CD28 is linked to systemic lupus erythematosus.